BSTZ
BlackRock Science·NYSE
--
--(--)
--
--(--)
BSTZ fundamentals
During FY 2025, BlackRock Science (BSTZ) reported revenue of 3.20M, a YoY change of -19.57%. Net income was 314.36M, a YoY change of 13.27%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
H1,2019 | FY,2019 | H1,2020 | FY,2020 | H1,2021 | FY,2021 | H1,2022 | FY,2022 | H1,2023 | FY,2023 | H1,2024 | FY,2024 | H1,2025 | FY,2025 | TTM |
|---|
Start Date | Jan 1, 2019 | Jan 1, 2019 | Jan 1, 2020 | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2022 | Jan 1, 2023 | Jan 1, 2023 | Jan 1, 2024 | Jan 1, 2024 | Jan 1, 2025 | Jan 1, 2025 | -- |
End Date | Jun 30, 2019 | Dec 31, 2019 | Jun 30, 2020 | Dec 31, 2020 | Jun 30, 2021 | Dec 31, 2021 | Jun 30, 2022 | Dec 31, 2022 | Jun 30, 2023 | Dec 31, 2023 | Jun 30, 2024 | Dec 31, 2024 | Jun 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 252.00K -- | 6.52M -- | 2.12M +742.37% | 3.40M -47.94% | 1.20M -43.38% | 2.09M -38.47% | 1.92M +59.79% | 3.47M +66.02% | 3.32M +72.68% | 6.15M +77.40% | 1.41M -57.44% | 3.98M -35.39% | 1.62M +14.97% | 3.20M -19.57% | 3.20M -- |
Operating Expenses | 156.82K -- | 10.28M -- | 10.84M +6813.19% | 26.95M +162.22% | 20.32M +87.43% | 42.19M +56.56% | 15.27M -24.84% | 26.85M -36.37% | 10.54M -30.97% | 21.31M -20.62% | 12.65M +19.94% | 24.56M +15.26% | -- -- | 21.21M -13.63% | 21.21M -- |
Selling, General and Administrative Expenses | 144.16K -- | 236.58K -- | 167.84K +16.43% | 486.86K +105.79% | 343.71K +104.78% | 830.22K +70.53% | 116.78K -66.02% | 575.72K -30.65% | 137.02K +17.33% | 388.48K -32.52% | 188.24K +37.38% | 315.77K -18.72% | -- -- | 309.59K -1.96% | 309.59K -- |
Other Operating Expenses | 12.66K -- | 246.90K -- | 239.02K +1787.54% | 885.74K +258.75% | 470.06K +96.66% | 829.36K -6.37% | 627.77K +33.55% | 802.05K -3.29% | 523.41K -16.62% | 945.17K +17.84% | 2.01M +283.61% | 3.37M +256.60% | -- -- | 1.04M -69.18% | 1.04M -- |
Operating Income | 95.18K -- | 113.23M -- | 430.27M +451968.54% | 1.49B +1211.50% | 403.28M -6.27% | 248.55M -83.26% | -1.16B -386.55% | -1.34B -637.54% | 229.10M +119.83% | 279.96M +120.95% | 161.40M -29.55% | 277.54M -0.86% | -- -- | 314.36M +13.27% | 314.36M -- |
Gain (Loss) on Change in Fair Value | -- -- | 145.70M -- | 545.20M -- | 1.44B +888.67% | 190.55M -65.05% | 29.94M -97.92% | -1.25B -754.82% | -1.43B -4875.33% | 280.46M +122.48% | 336.01M +123.51% | 138.13M -50.75% | 170.69M -49.20% | -- -- | 70.05M -58.96% | 70.05M -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | 85.19K -- | -14.63K -- | -348.35K -508.90% | -238.39K -1529.66% | -597.51K -71.52% | -171.30K +28.14% | -256.94K +57.00% | -260.68K -52.17% | -425.11K -65.45% | -134.00K +48.59% | -254.87K +40.05% | -- -- | -436.80K -71.38% | -436.80K -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 14.40K -- | 16.20K -- | -- -- | 546 -96.63% | 546 -- |
Interest Income | -- -- | 5.46M -- | 2.03M -- | 3.30M -39.67% | 1.16M -42.76% | 2.09M -36.72% | 1.91M +65.09% | 3.55M +69.93% | 3.71M +93.51% | 6.84M +92.90% | 3.79M +2.38% | 6.44M -5.80% | -- -- | 3.28M -49.13% | 3.28M -- |
Pretax Income From Continuing Operations | 95.18K -- | -3.75M -- | -8.72M -9260.15% | -23.55M -527.43% | -19.12M -119.28% | -40.10M -70.26% | -13.35M +30.16% | -23.38M +41.70% | -7.23M +45.88% | -15.16M +35.17% | -11.25M -55.66% | -20.61M -36.00% | -8.28M +26.41% | -18.02M +12.60% | -18.02M -- |
Other Items Before Net Income | 6.34M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | 6.43M -- | 113.23M -- | 430.27M +6586.81% | 1.49B +1211.50% | 403.28M -6.27% | 248.55M -83.26% | -1.16B -386.55% | -1.34B -637.54% | 229.10M +119.83% | 279.96M +120.95% | 161.40M -29.55% | 277.54M -0.86% | 27.84M -82.75% | 314.36M +13.27% | 314.36M -- |
Net Income Attributable to Owners of the Company | 6.43M -- | 113.23M -- | 430.27M +6586.81% | 1.49B +1211.50% | 403.28M -6.27% | 248.55M -83.26% | -1.16B -386.55% | -1.34B -637.54% | 229.10M +119.83% | 279.96M +120.95% | 161.40M -29.55% | 277.54M -0.86% | -- -- | 314.36M +13.27% | 314.36M -- |
Net Income Attributable to Common Stockholders | 6.43M -- | 113.23M -- | 430.27M +6586.81% | 1.49B +1211.50% | 403.28M -6.27% | 248.55M -83.26% | -1.16B -386.55% | -1.34B -637.54% | 229.10M +119.83% | 279.96M +120.95% | 161.40M -29.55% | 277.54M -0.86% | -- -- | 314.36M +13.27% | 314.36M -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | 113.23M -- | 430.27M -- | 1.49B +1211.50% | 403.28M -6.27% | 248.55M -83.26% | -1.16B -386.55% | -1.34B -637.54% | 229.10M +119.83% | 279.96M +120.95% | 161.40M -29.55% | 277.54M -0.86% | -- -- | 314.36M +13.27% | 314.36M -- |
Basic EPS | 0.09 -- | 1.62 -- | 5.51 +6022.22% | 19.02 +1074.07% | 5.16 -6.35% | 3.18 -83.28% | -14.71 -385.08% | -17.01 -634.91% | 2.96 +120.12% | 3.62 +121.28% | 2.12 -28.38% | 3.74 +3.31% | 0.41 -80.66% | 4.57 +22.19% | 4.57 -- |
You can ask Aime
Did BlackRock Science beat or miss consensus estimates last quarter?What does BlackRock Science do and what are its main business segments?What were the key takeaways from BlackRock Science’s earnings call?What is BlackRock Science's latest dividend and current dividend yield?What guidance did BlackRock Science's management provide for the next earnings period?What is the revenue and EPS growth rate for BlackRock Science year over year?What is BlackRock Science's gross profit margin?What factors drove the changes in BlackRock Science's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
